Recap: Werewolf Therapeutics Q4 Earnings

Werewolf Therapeutics HOWL reported its Q4 earnings results on Thursday, March 7, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Werewolf Therapeutics beat estimated earnings by 23.0%, reporting an EPS of $-0.33 versus an estimate of $-0.43.

Revenue was down $5.78 million from the same period last year.

Last quarter the company beat on EPS by $0.16 which was followed by a 0.0% increase in the share price the next day.

Here's a look at Werewolf Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.39	-0.42	-0.50	-0.55
EPS Actual	-0.23	-0.14	-0.34	-0.39
Revenue Estimate	1.59M	2.46M	5.00M	2.07M
Revenue Actual	5.90M	8.08M	4.46M	7.28M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Werewolf Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar